cobaltous chloride has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartz-Schmidt, KU; Dick, HB; Fehr, M; Herms, F; Hurst, J; Joachim, SC; Kuehn, S; Maliha, AM; Schnichels, S | 1 |
| Barthel, H; Burchert, W; Dannenberg, C; Kämpfer, I; Kluge, R; Knapp, WH; Seese, A | 1 |
2 other study(ies) available for cobaltous chloride and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Diminished apoptosis in hypoxic porcine retina explant cultures through hypothermia.
Topics: Amacrine Cells; Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Cell Hypoxia; Cobalt; Cold Temperature; In Vitro Techniques; Microglia; Neurodegenerative Diseases; Reactive Oxygen Species; Retinal Bipolar Cells; Retinal Diseases; Retinal Ganglion Cells; Swine | 2019 |
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Disorders; Cobalt; Cysteine; Depression; Drug Stability; Female; Humans; Male; Methylene Blue; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Scalp; Sensitivity and Specificity; Sleep Apnea Syndromes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |